Hi all - FYI my registration for this briefing has been confirmed, though it took a couple of days over the long weekend. For interest, here are my draft questions:
1. Has the Elanco Phase II Dog Dossier been submitted and what are the next milestones for an agreement?
2. When will the MPL Phase II Human Cancer trial design be communicated and when will it start?
3. What are the next steps for MPL SARS-CoVID trials and how well does this fit with PAA Strategy?
4. Is the Epichem customer contract pipeline growing and profitable in these challenging times?
If there are better questions that I can ask let me know.
Regards
- Forums
- ASX - By Stock
- PAA
- Ann: Virtual Investor Briefing
Ann: Virtual Investor Briefing, page-29
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
16.5¢ |
Change
0.005(3.13%) |
Mkt cap ! $80.22M |
Open | High | Low | Value | Volume |
16.5¢ | 17.5¢ | 16.5¢ | $276.1K | 1.636M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 379426 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 379426 | 0.165 |
9 | 219941 | 0.160 |
4 | 512800 | 0.155 |
13 | 2431665 | 0.150 |
2 | 21442 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 10000 | 1 |
0.175 | 211484 | 3 |
0.180 | 163500 | 3 |
0.185 | 375000 | 1 |
0.190 | 568698 | 5 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
NEWS
Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
NEWS
Is oil undervalued?
PAA (ASX) Chart |